InVivo Therapeutics Holdings Corp
NVIV
NVIV: InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.
moreShow NVIV Financials
Recent trades of NVIV by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NVIV's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Poly((lactic-co-glycolic acid)-b-lysine) and process for synthesizing a block copolymer of plga {poly(lactic-co-glycolic acid)} and pll (poly-ϵ-cbz-l-lysine) Nov. 20, 2018
Federal grants, loans, and purchases
Followers on NVIV's company Twitter account
Number of mentions of NVIV in WallStreetBets Daily Discussion
Recent insights relating to NVIV
Recent picks made for NVIV stock on CNBC
ETFs with the largest estimated holdings in NVIV
Flights by private jets registered to NVIV